Best Practices in Testing in Opioids

One of the key recommendations from the CDC Guideline for Prescribing Opioids for Chronic Pain is to conduct urine drug testing (UDT) before starting opioid therapy and consider annual testing to assess for prescribed and illicit drugs. However, ordering and interpreting UDTs can be complex, and unexpected results can be difficult to manage. That's where our expertise comes in.

We are a team of experienced toxicologists who specialize in opioid testing. We understand the nuances of the different types of UDTs and can guide you in choosing the best test for your patient. Whether it's immunoassay testing or the more advanced gas chromatography/mass spectrometry, we can help you interpret the results accurately and provide actionable recommendations for patient management.

We believe in patient-centered care and recognize the importance of building trust with your patients. We offer tips on how to discuss UDTs with your patients, from explaining the purpose of the test to discussing the potential cost. We provide guidance on what actions to take post-testing, including reviewing the treatment agreement and increasing monitoring if necessary.

At our website, you'll find a wealth of information on toxicology testing for opioids. We cover topics such as unexpected results, random repeat testing, and the use of the CDC mobile app for practice conversations. We also provide a detailed comparison of the two main types of UDTs, immunoassay and gas chromatography/mass spectrometry, so you can make an informed decision for your patient.

We understand the challenges of prescribing opioids for chronic pain, and our goal is to provide you with the knowledge and tools to ensure the safe and effective use of these medications. Our website is a valuable resource for physicians looking to stay up-to-date on best practices in toxicology testing for opioids. Thank you for visiting, and we look forward to working with you.